EVOLVA BIOTECH A/S: Financial statements 2012
CVR: 25532538
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
EVOLVA BIOTECH A/S (CVR 25532538) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 19,095,836 and a net result of DKK -1,978,389. The profit margin was -10.4%. Equity in the 2012 report amounted to DKK 8,243,905. The solvency ratio was 25.7%.
- Revenue
- DKK 19,095,836
- Gross Profit
- DKK 12,648,276
- Profit/Loss
- DKK -1,978,389
- Equity
- DKK 8,243,905
- Total Assets
- DKK 32,086,728
Official annual report
Keep an eye on EVOLVA BIOTECH A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout EVOLVA BIOTECH A/S
EVOLVA BIOTECH A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 2000. The company has been dissolved on 17 June 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ARPIDA A/S and COMBIO A/S. The company has 2 employees (2018). In 2020, the company reported a gross profit of DKK -116,208 and a net result of DKK -196,806 compared with DKK -187,015 the year before. Equity in the 2020 report amounted to DKK 6,378,584.